Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | aldehyde dehydrogenase 1 family, member A1 | Starlite/ChEMBL | No references |
Homo sapiens | thyroid stimulating hormone receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Succinate-semialdehyde dehydrogenase [NADP+] dependent (SSDH) GabD1 | aldehyde dehydrogenase 1 family, member A1 | 501 aa | 456 aa | 33.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | myelin transcription factor 1 myt1 | 0.0093 | 0.0806 | 0.0674 |
Echinococcus granulosus | chromobox protein 2 | 0.0191 | 0.2028 | 0.3253 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0073 | 0.0563 | 0.0728 |
Schistosoma mansoni | sex comb on midleg homolog | 0.0257 | 0.2856 | 0.2754 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.0563 | 0.5 |
Echinococcus multilocularis | suppression of tumorigenicity 18 protein | 0.0093 | 0.0806 | 0.1147 |
Echinococcus granulosus | tumor suppressor p53 binding protein 1 | 0.0317 | 0.3599 | 0.5962 |
Echinococcus granulosus | Jumonji AT rich interactive domain 1B | 0.0111 | 0.1026 | 0.1527 |
Brugia malayi | mbt repeat family protein | 0.0268 | 0.2986 | 0.5001 |
Echinococcus granulosus | lysine specific demethylase 5A | 0.009 | 0.0772 | 0.1089 |
Echinococcus multilocularis | polycomb protein SCMH1 | 0.0257 | 0.2856 | 0.4682 |
Schistosoma mansoni | scm-relatedprotein containing 4 mbt domains (sfmbt) | 0.0373 | 0.4294 | 0.4212 |
Echinococcus multilocularis | Jumonji, AT rich interactive domain 1B | 0.0111 | 0.1026 | 0.1527 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.009 | 0.0772 | 0.064 |
Plasmodium falciparum | JmjC domain-containing protein, putative | 0.0028 | 0 | 0.5 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.009 | 0.0772 | 0.064 |
Brugia malayi | follicle stimulating hormone receptor | 0.0282 | 0.3167 | 0.5415 |
Echinococcus multilocularis | endonuclease exonuclease phosphatase | 0.0505 | 0.5941 | 1 |
Echinococcus multilocularis | SAM and MBT domain containing protein | 0.0373 | 0.4294 | 0.7161 |
Loa Loa (eye worm) | hypothetical protein | 0.0443 | 0.5167 | 1 |
Echinococcus granulosus | SAM and MBT domain containing protein | 0.0373 | 0.4294 | 0.7161 |
Echinococcus granulosus | polycomb protein SCMH1 | 0.0257 | 0.2856 | 0.4682 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0073 | 0.0563 | 0.0428 |
Echinococcus granulosus | histone acetyltransferase MYST2 | 0.0093 | 0.0806 | 0.1147 |
Schistosoma mansoni | hypothetical protein | 0.0317 | 0.3599 | 0.3507 |
Loa Loa (eye worm) | mbt repeat family protein | 0.0268 | 0.2986 | 0.5001 |
Loa Loa (eye worm) | follicle stimulating hormone receptor | 0.0282 | 0.3167 | 0.5415 |
Echinococcus multilocularis | tumor suppressor p53 binding protein 1 | 0.0317 | 0.3599 | 0.5962 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0133 | 0.1302 | 0.1139 |
Plasmodium vivax | JmjC domain containing protein | 0.0028 | 0 | 0.5 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0073 | 0.0563 | 1 |
Schistosoma mansoni | sex comb on midleg homolog | 0.0257 | 0.2856 | 0.2754 |
Toxoplasma gondii | PLU-1 family protein | 0.0043 | 0.0179 | 0.2669 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0073 | 0.0563 | 0.0728 |
Onchocerca volvulus | Polycomb protein Sfmbt homolog | 0.0443 | 0.5167 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.0563 | 0.5 |
Echinococcus multilocularis | lysine specific demethylase 5A | 0.0075 | 0.0585 | 0.0766 |
Brugia malayi | jmjC domain containing protein | 0.0133 | 0.1302 | 0.1139 |
Brugia malayi | mbt repeat family protein | 0.0443 | 0.5167 | 1 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0073 | 0.0563 | 0.5 |
Echinococcus multilocularis | chromobox protein 2 | 0.0191 | 0.2028 | 0.3253 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0073 | 0.0563 | 0.0428 |
Echinococcus multilocularis | histone acetyltransferase MYST2 | 0.0093 | 0.0806 | 0.1147 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.0563 | 0.5 |
Schistosoma mansoni | chromobox protein | 0.0191 | 0.2028 | 0.1914 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0073 | 0.0563 | 0.5 |
Echinococcus granulosus | endonuclease exonuclease phosphatase | 0.0505 | 0.5941 | 1 |
Echinococcus granulosus | suppression of tumorigenicity 18 protein | 0.0093 | 0.0806 | 0.1147 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 6.3096 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 6.3096 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 8.9125 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | 11.6891 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.